Medical Equipment

Self-Monitoring Blood Glucose (SMBG) Devices Industry Forecast to Hit $22.35 Billion by 2029 With a Strong 8.4% CAGR

November 14, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Growth Projections For The Self-Monitoring Blood Glucose (SMBG) Devices Market Size During 2025–2029?#_x000D_

The market for self-monitoring blood glucose (smbg) devices has experienced robust expansion lately, projected to increase from $\$15.23$ billion in 2024 to $\$16.19$ billion in 2025, reflecting a compound annual growth rate (CAGR) of $6.3\%$. This historical period’s upward trend stems from several key factors, including the expanding incidence of diabetes, heightened public consciousness regarding healthcare, a demographic shift towards an older population, governmental programs and compliance requirements, and escalating expenditures within the healthcare sector._x000D_

_x000D_

Anticipation surrounds the self-monitoring blood glucose (smbg) devices sector, projecting robust expansion ahead, as its market valuation is set to reach $22.35 billion by 2029, climbing steadily at a compound annual growth rate (CAGR) of 8.4%; this upswing during the prediction horizon is fueled by several factors, notably the increase in home-based medical care, the broadening reach of telehealth services, augmenting personal disposable income, heightened consumer desire for remote health surveillance, and the growing prevalence of e-commerce platforms, while key shifts influencing this period are characterized by the incorporation of continuous glucose monitoring (CGM) technology, the implementation of artificial intelligence (AI) alongside machine learning capabilities, the emergence of wearable smbg gadgets, advancements toward non-invasive monitoring methods, and improvements in mobile application integration and overall device connectivity._x000D_

_x000D_

#Unlock Your Free Sample Report for Exclusive Market Data:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=6969&type=smp_x000D_

_x000D_

#What Are The Drivers Pushing New Developments In The Self-Monitoring Blood Glucose (SMBG) Devices Market?#_x000D_

The escalating incidence of diabetes is projected to fuel the expansion of the market for self-monitoring blood glucose apparatuses in the coming period. This technique involves individuals managing diabetes utilizing a blood sugar measurement instrument, commonly called a glucose meter, allowing them to assess or modify the efficacy of their therapeutic regimen, which includes diet, physical activity, insulin administration, and anti-diabetic medications, or to consult with their healthcare provider based upon the readings obtained. As an illustration, data released in March 2024 by the UK’s Office for Health Improvement & Disparities indicated significant positive shifts in care metrics between March 2022 and March 2023: a 22% rise in type 1 diabetic patients receiving all eight essential care procedures and a 21% uptick for type 2 diabetics, alongside the National Diabetes Audit (NDA) reporting a record high of 37.9% achieving target HbA1c levels. Consequently, the increased occurrence of diabetes serves as a catalyst accelerating the progression of the market for self-monitoring blood glucose equipment._x000D_

_x000D_

#Which Key Segments Fueling The Self-Monitoring Blood Glucose (SMBG) Devices Market?#_x000D_

The self-monitoring blood glucose (smbg) devicesmarket covered in this report is segmented – _x000D_

_x000D_

1) By Product: Self-Monitoring Blood Glucose Meters, Continuous Glucose Monitors, Testing Strips, Lancets_x000D_

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics & Centers_x000D_

3) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes_x000D_

_x000D_

Subsegments:_x000D_

1) By Self-Monitoring Blood Glucose Meters: Traditional Glucose Meters, Smart Glucose Meters_x000D_

2) By Continuous Glucose Monitors (CGMs): Real-Time CGMs, Flash Glucose Monitoring Systems_x000D_

3) By Testing Strips: Standard Testing Strips, Test Strips for Specific Meters_x000D_

4) By Lancets: Standard Lancets, Safety Lancets_x000D_

_x000D_

#What Are The Major Trends Driving The Growth Of The Self-Monitoring Blood Glucose (SMBG) Devices Market?#_x000D_

The self-monitoring blood glucose devices sector is currently experiencing a significant surge driven by technological progress. Leading firms within this market are dedicating efforts toward innovating sophisticated products as a means to bolster their competitive standing. Specifically, the US enterprise Know Labs Inc., renowned for producing glucose measurement apparatus, introduced KnowU, a novel, portable, medical-grade glucose monitoring unit that leverages Bio-RFID principles. This innovation represents a completely non-invasive system for tracking glucose, featuring a base unit for powering and displaying metrics alongside a portable, battery-operated sensor module enabling users to check their sugar concentrations wherever they travel. Consequently, the KnowU stands out as an economical and user-friendly alternative when contrasted with existing monitoring instruments that are often costly and require painful procedures._x000D_

_x000D_

#Which Major Industry Participants Are Leading The Self-Monitoring Blood Glucose (SMBG) Devices Market Growth?#_x000D_

Major companies operating in the self-monitoring blood glucose (SMBG) devices market include Abbott Laboratories, Bionime Corporation, B. Braun Melsungen AG, F. Hoffmann-La Roche Ltd, LifeScan Inc, PHC Holdings Corporation, Home Diagnostics Inc, Terumo Pharmaceutical Solutions, ARKRAY Inc, Ypsomed Holding AG, Dexcom Inc, Medtronic plc, Novo Nordisk A/S, Glysens Incorporated, Senseonics Holdings Inc., AgaMatrix Inc., All Medicus Co. Ltd., Ascensia Diabetes Care Holdings AG, Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bioptik Technology Inc., Cnoga Medical Ltd., ForaCare Inc., Glucovation Inc., Hainice Medical Inc., Infopia Co. Ltd., Insulet Corporation, Integrity Applications, Johnson & Johnson, Menarini Diagnostics, Nemaura Medical Inc., Nipro Corporation, Nova Biomedical Corporation, Omron Healthcare Inc., Optiscan Biomedical Corporation, OrSense Ltd., Pinnacle Technology Inc., Prodigy Diabetes Care LLC, PTS Diagnostics, TaiDoc Technology Corporation, Trividia Health Inc., WaveForm Technologies Inc. _x000D_

_x000D_

#Download The Full Report For Exclusive Market Findings:#_x000D_

https://www.thebusinessresearchcompany.com/report/self-monitoring-blood-glucose-smbg-devices-global-market-report_x000D_

_x000D_

#What Are The Key Regional Factors Influencing The Self-Monitoring Blood Glucose (SMBG) Devices Market Growth?#_x000D_

North America was the largest region in the self-monitoring blood glucose (SMBG) devices market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the self-monitoring blood glucose (SMBG) devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_

_x000D_

#Request A Customized Version Of The Self-Monitoring Blood Glucose (SMBG) Devices Market Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=6969&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2025, By The Business Research Company#_x000D_

_x000D_

Hematology Drug Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report_x000D_

_x000D_

Peripheral Vascular Devices And Equipment Global Market Report 2025_x000D_

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report_x000D_

_x000D_